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AN appreciable increase in the radiosensitivity ofthe C3H mammary carcinoma
was observed when the tumour-bearing mice were inoculated subcutaneously,
about 2 weeks prior to treatment, withfragments oftumour or ofisogenic neonatal
skin previously irradiated with doses of 5000-7000 r (Cohen and Cohen, 1957).
Since these isologous tissues are not normally antigenic, it was concluded that the
attenuatingprocedure hadchangedsome specific "identitymarkers " inthe tumour
and skin inocula, equivocating their isogenic pattern, thus evoking a type of
homograft reaction in the host. This disturbance of the balance between the
growing tumour and its host resulted in an enhanced response of the tumour
to a comparatively small dose of radiation.
If radiation-attenuated isologous tissues act in this way, that is, by virtue of
new antigenic constituents, resembling, but notidentical with the tumour antigens,
then unirradiated homologous tissues from other mouse strains or closely related
species should also have a radiosensitizing action. The following experiments
were designed to test this hypothesis.
MATERIALS AND METHODS
Experimental design
Young adult male mice of the C3H/Cg strain were used as tumour recipients
in all experiments. Each of the 164 animals was inoculated subcutaneously in
the right axillary region with a fragment of tumour introduced by means of a
trocar and cannula. When the isografts became palpable about 2-3 weeks later,
the second inoculum was minced finely with small scissors, either irradiated or
not, as indicated, and implanted subcutaneously with trocar and cannula into the
left flank. Eleven experimental categories, as listed in Table I, were investigated.
In the 3 groups receiving grafts ofhybrid skin, neonatal mice with thefollowing
genotypes were used: (a) The F1 offspring of a C3H male and a non-inbred stock
albino female; (b) Backcross mice, offspring of an F1 hybrid female (from "a ")
and a C3H male; and (c) Backeross mice from crossing an F1 male (from" a
with a stock albino female.
In the 4 " homograft " groups, the skin was obtained from neonatal outbred
albino mice, and spleen and kidney from young adults of the same stock. In one
group of this series the skin was inoculated without further preparation in the
manner described. In a second group, the skin was minced, placed in a plastic
welled slide and irradiated with 7000 r prior to inoculation. A third batch of skin
was minced and emulsified in an equal volume of Freund's adjuvant with M.
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butyricum suspension (" Bacto-Adjuvant ", Difco) before inoculation. Spleen
and kidney homografts were inoculated into smaller groups of 4 and 5 tumour-
bearing mice respectively.
In the 2 " heterospecific " groups, skin was removed from non-inbred newborn
stock albino rats, minced, irradiated in one instance, and inoculated as described.
Of the 2 " heterogeneric " groups, in one case skin was removed by surgical
excision from an anaesthetized adult baboon, then minced and inoculated; and
in the other, 0 1 ml. of an emulsion of equal parts of normal saline and Freund's
adjuvant with M. butyricum, was injected by hypodermic syringe.
Irradiation technique
The standard procedures for irradiation of the tumours in situ, and of minced
tissues in vitro prior to inoculation, have been described in detail in previous
papers (Cohen and Cohen, 1953, 1957).
All irradiated inocula received 7000 r after being minced and sealed in a plastic
welled slide.
The tumours were treated in situ with a standard test dose of 4200 r when
they had attained a diameter ofabout 1 cm., that is 4-7 weeks after implantation,
and 2-5 weeks after the second inoculation. The expectation of cure at this dose,
without preparatory sensitization, is about 0.1 per cent, so that two or more cures
in any single experimental group may be taken as indicative of a significant
induced radiosensitization.
RESULTS
The results of all the experiments are shown in Table I. The first three items
included for comparison, are from previous data. It can be seen that living
homologous skin from closely related donors, F1 hybrids and backcross mice,
as well as other homologous tissues, and even heterologous skin from a related
genus, did in fact succeed in sensitizing the tumour.
Although the difference in the cure-rate between the hybrid graft groups
(16 per cent) and the homograft group (32 per cent) is not statistically significant,
a trend becomes apparent, on grouping the data, which indicates that the cure-
rate of the tumour is influenced by the-particular degree of antigenic dissimilarity
between the host's tissues and the inoculum. Thus, unirradiated isologous skin
which is by nature non-antigenic to the host, is not effective as a radiosensitizer
(0/22 cures), whereas hybrid grafts containing both isologous and homologous
protein components are somewhat more effective (16 per cent cures). One can
assume that the quantities of the genetic components in the hybrids varied, that
is, that the inocula from the F1 group were half homologous, and those from the
(C3H x F1) backcross and the (F1 x albino stock) backcross mice were one-
quarter and three-quarters homologous respectively, yet no significant difference
in cure-rates among the recipient mice could be demonstrated. This seems to
indicate that the mere presence of the homologous component, irrespective of its
proportional concentration in each genetic combination, was the deciding factor.
The overall cure rateinthe homograftgroup was 32 per cent, withno significant
differences between the irradiated and the unirradiated skin homografts (in
contrast with the difference between irradiated and unirradiated isografts), and,
as has been previously noted (Cohen and Cohen, 1957), the addition of Freund's
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TABLE I.-Radiosensitization of the C3H Mammary Tumour Induced by
Tissue Grafts of Various Origins
Dose in situ 4200 r
Grouiped totals
Nurnber Nuiiber ,--
Sensitizing inoculuiii of mice cured Type Cures
0
Total uiinoculated controls* 108 0 -
Irradiated C3H tissues and tun-ours* .208 62
Unirradiated isologous (C3H) skin* .22 0 Isografts 0
(C3H x stock albiino) F1 hybrid skin .. 21 2 ) Hybrid
(C3H x F1) backcross skin 1 3 16
(Fl x stock albino) backeross skin . 12 2 grafs
Uiiirladiated newborn albinio mouse skiin . 44 15
Irradiated newborn albino rnouse skin 10 2 Hoinogiafts 32
Albino rnouse skin + Freund's adjuvant 11 r
Adult albino tissues (spleen, kidney) 9 3
Uliiirradi<ated newborn albino rat skin 11 0 ) Heteroo-
specific 18
Irradiated newborn albino rat skil . 11 . 4 J grafts
Unirradiated adult baboon skin . 1 0 Hetero-
>generic 0
lkl. butyricutmz emulsion (Freund's) 13 0 J protein
*Fromii previous data, Cohen and Cohein, 1957.
adjuvant to the inoculum did not significantly enhance the response ofthe tumour
to radiation. The effect of other homologous organs, one predominantly epithelial
tissue (kidney, 2/5 cures), and one predominantly connective tissue (spleen,
1/4 cures) also did not differ significantly from that of skin, although these experi-
ments were done on rather small groups of mice.
As the genetic and antigenic constitution of the inocula diverged more widely
from those of the C3H mouse, the cure-rate tended to fall; skin from a different,
but related species (rat), yielding 18 per cent cures in a pooled group of 22 mice,
and tissue from a primate (baboon) aswell as asuspension ofbacteria (M. butyricum)
yielding no cures in a pooled group of 24 mice.
DISCUSSION
The foregoing results appear to confirm the prediction that unirradiated
homologous tissues and radiation-attenuated isologous tissues have similar
radiosensitizing effects. The inoculation of both types of " antigen " into tumour-
bearing animals amounts to the super-imposition of " equivocated information "
upon thehost-tumoursystem, andifthenewinformationisnotreadilydistinguished
from the existing tumour signal-pattern, it will disturb the relatively tolerant
host-tumour relationship. This would be expected to amplify the effects of local
irradiation, and hence account for the induced radiosensitization of tumours.
It is also interesting to note that homografts have the maximum radiosensitiz-
ing capacity which is presumably associated with an optimal antigenic stimulus.
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genetically to the tumour-bearing mouse give inferior results. In this respect,
the variation in the cure-rate ofthe tumour as a function ofthe changing immuno-
genetic characteristics of the sensitizing inocula resembles that obtained in the
case of isografts subjected to increasing attenuating doses of ionizing radiation
(Cohen and Cohen, 1957). One might speculate that the optimal attenuating dose
of radiation converts the isograft to a virtual homograft, while higher doses
denature the isograft beyond this stage so that it acts like any non-specific foreign
protein.
It would seem that, whatever type of antigenic stimulus is applied to this
particular host-tumour relationship, it is apparently not possible to obtain cure-
rates beyond a maximum of about 50 per cent at the standard test-dose of 4200 r
(Cohen and Cohen, 1957). SincetheLD50ofthenon-sensitized tumourhasremained
consistently at 5700 r throughout this series of experiments (Cohen and Cohen,
1953; and unpublished data, 1958), the maximum degree of radiosensitization
obtainable may be estimated by the ratio of these two doses. In other words,
the radiosensitivity can be increased by no more than a factor of 36 per cent. This
slight increase in curability seems to be a fundamental limitation of the stable
C3Hisologous host-tumourrelationship, anditishighlyimprobablethatanybetter
results could be obtained by this approach in the therapy of human tumours.
However, since a sensitized tumour mightrespond to adoseofaboutthree-quarters
of that normally required, the technique could have some limited application in
clinical therapy of radio-resistant tumours.
SUMMARY
C3H mice bearing isografts of the mammary adenocarcinoma were each given
a single inoculum of (1) hybrid neonatal skin from (C3H x stock albino) F1,
(F1 x stock albino) backcross, and (C3H x F1) backcross mice; (2) irradiated
and unirradiated homologous neonatal skin from stock albino mice, homologous
neonatal skin emulsified in Freund's adjuvant, and homologous spleen and kidney
from adult stock albino mice; (3) irradiated and unirradiated rat neonatal skin;
and (4) completely foreign proteins in the form of baboon skin and of Mycobac-
terium butyricum with Freund's adjuvant. This was followed in 2-5 weeks by
treatment ofthe tumour in situ with a test dose of 4200 r, a dose level at which the
expectation of cure in control mice is about 0 1 per cent. The overall cure rate in
the hybrid-graft groups was 16 per cent, in the homograft groups 32 per cent, in
the heterospecific-graft groups 18 per cent, and, in the heterogeneric groups there
were no cures. This trend seemed to indicate that optimal radiosensitization of
the tumour could be obtained where the antigenic constituents of the inocula
resembled, but were neither identical with, nor too divergent from, the antigens
of the tumour and the host.
The limitations of this combined immunological and radiotherapeutic attack
on stable isologous and autologous host-tumour relationships are discussed.
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